Shares of Kimberly-Clark Corp. fell 3.1% in premarket trading Tuesday, after the parent of consumer brands including Huggies diapers, Kleenex tissues and Scott toilet paper reported third-quarter ...

Kimberly-Clark Corporation (NASDAQ:KMB) is known for offering a broad range of everyday household products, including diapers, tissues, and feminine care items.

Kimberly-Clark Corporation (NASDAQ: KMB) is included among the 11 Best Halal Dividend Stocks to Buy Now. A stack of disposable diapers in the foreground with a mother and her baby in the background.

Months after Trump Jr. breakup shake-up and "ambassador school," is Kimberly Guilfoyle headed to Greece? Senate Confirmation Hearing was July 9, 2025.

Kimberly-Clark's cost-saving plans aim for $200M in SG&A by 2027, boosted by global tissue market growth. Find out why KMB is an attractive long-term investment.

Kimberly-Clark Corp. has agreed to sell a majority stake in its global Kleenex and tissue businesses outside of North America to a newly-formed venture with Brazilian pulp supplier Suzano SA.

Kimberly-Clark on Thursday struck a deal with Brazilian pulp maker Suzano to sell a majority stake in its international tissue business, valuing the business at about $3.4 billion, the Kleenex ...

Kimberly-Clark on Thursday announced a partnership with Brazilian pulp and paper producer Suzano to split ownership of Kimberly-Clark's international tissue and paper products business.

business | Local Companies Irving-based Kimberly-Clark selling international arm for $3.4B Kimberly-Clark will still have a 49% interest in the new venture.

Kimberly-Clark will own a 49% interest in the new venture, which will include substantially all the assets of its International Family Care and Professional business, and Suzano will own 51%.

Kimberly-Clark KMB -0.30% struck a more than $3 billion deal for its Kleenex and tissue businesses outside of North America as the maker of Scott toilet paper and Huggies diapers aims to focus on ...

Suzano S.A. and Kimberly-Clark Corporation announced a $3.4 billion joint venture to create an international tissue company.